The splicing factor DHX38/PRP16 is required for ovarian clear cell carcinoma tumorigenesis, as revealed by a CRISPR‐Cas9 screen

Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes

(2021) Angiolo Gadducci et al.   GYNECOLOGIC ONCOLOGY

Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids

(2020) Birgitta E. Michels et al.   Cell Stem Cell

Roles and mechanisms of alternative splicing in cancer — implications for care

(2020) Sophie C. Bonnal et al.   Nature Reviews Clinical Oncology

Clear cell carcinoma of the ovary: a clinical and molecular perspective

(2020) Yasushi Iida et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Targeting PI3K in cancer: mechanisms and advances in clinical trials

(2019) Jing Yang et al.   Molecular Cancer

Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer

(2019) Adrian P. Bracken et al.   GENES & DEVELOPMENT

Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study

(2018) Fei-Chun Ku et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Clear cell carcinoma of the ovary

(2018) Haosha Tang et al.   MEDICINE

The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations

(2018) Liang Chen et al.   MOLECULAR CELL

CRISPR/Cas9 for cancer research and therapy

(2018) Tianzuo Zhan et al.   SEMINARS IN CANCER BIOLOGY

USP39 Deubiquitinase Is Essential forKRASOncogene-driven Cancer

(2017) Julia M. Fraile et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells

(2017) Robin M Meyers et al.   NATURE GENETICS

Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening

(2017) Julia Joung et al.   Nature Protocols

Postcatalytic spliceosome structure reveals mechanism of 3′–splice site selection

(2017) Max E. Wilkinson et al.   SCIENCE

Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression

(2017) Se Hoon Hong et al.   Oncotarget

Protein DHX38 is a novel inhibitor of protein phosphatase 4

(2015) Sueji Han et al.   Animal Cells and Systems

High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities

(2015) Traver Hart et al.   CELL

MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis

(2015) Cheryl M. Koh et al.   NATURE

Improved vectors and genome-wide libraries for CRISPR screening

(2014) Neville E Sanjana et al.   NATURE METHODS

Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells

(2013) K Kurokawa et al.   ONCOGENE

Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research

(2013) Michael S. Anglesio et al.   PLoS One

DEAD box RNA helicase functions in cancer

(2013) Frances V. Fuller-Pace   RNA Biology

Dynamic Protein-Protein Interaction Wiring of the Human Spliceosome

(2012) Anna Hegele et al.   MOLECULAR CELL

Proteasome Inhibitors Induce p53-Independent Apoptosis in Human Cancer Cells

(2011) Bulbul Pandit et al.   AMERICAN JOURNAL OF PATHOLOGY

PUMA is directly activated by NF-κB and contributes to TNF-α-induced apoptosis

(2009) P Wang et al.   CELL DEATH AND DIFFERENTIATION

PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium

(2009) Huaiyu Mi et al.   NUCLEIC ACIDS RESEARCH

PUMA, a potent killer with or without p53

(2009) J Yu et al.   ONCOGENE